Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Acute Pain × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 5 Neoplasm Metastasis 4 Colonic Neoplasms 4 Prostatic Neoplasms 3 Rectal Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Hyperthermia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Ovarian Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1 Metabolic Syndrome 1 Liver Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1

Interventions

Ketamine 2 Diclofenac 2 Anesthesia, General 2 Acetaminophen 2 Tea 1 Quality of Life 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Oxycodone 1 Minocycline 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Hydromorphone 1 Gabapentin 1 Ethyl Chloride 1 Epinephrine 1 Duloxetine Hydrochloride 1 Diathermy 1 Cryotherapy 1 Bupivacaine 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡